Sanjay Shukla, President and CEO at aTYR PHARMA INC (LIFE), bought 15,000 shares at $2.88 ($43K) on 2022-07-01, disclosed to the SEC on 2022-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| LIFE | BUY | 2023-12-12 | $18K | — | Filing → |
| LIFE | BUY | 2023-11-13 | $17K | — | Filing → |
| LIFE | BUY | 2023-08-01 | $30K | — | Filing → |